Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study
Title:
Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study
Author:
Haine, Valérie Oneko, Martina Debois, Muriel Ndeketa, Latif Agyapong, Prince Darko Boahen, Owusu Harrison, Samuel B E Adeniji, Elisha Kaali, Seyram Kayan, Kingsley Owusu-Agyei, Seth French, Neil Kariuki, Simon Devadiga, Raghavendra Ogutu, Bernhards Ansah, Nana Akosua Orsini, Mattea Ansah, Patrick Odum Maleta, Kenneth Ong'echa, John Michael Phiri, Vincent Katunga Mzanga, Phylis Jere, Tikhala Makhaza Azongo, Daniel K Mategula, Donnie Orimbo, John Oduro, Abraham Rexford Otieno, Walter Kaburise, Michael Bandasua Ababio, Lucy Osei Sifuna, Peter M Amoit, Stellah Kevyne Olewe, Fredrick Oyieko, Janet Nyawira Achieng Oguk, Esther Guerra Mendoza, Yolanda Awuni, Denis Sing'oei, Valentine Onyango, Irene Schuerman, Lode Ochieng, Benard Omondi Okoth, George Odhiambo Nyangulu, Wongani Cherop, Reuben Yego Odera-Ojwang, Patricia Cravcenco, Cristina Chipatala, Raphael Roman, François Savic, Miloje Asante, Kwaku Poku
Appeared in:
The Lancet global health
Paging:
Volume 13 () nr. 6 pages e995-e1005
Year:
2025
Contents:
Publisher:
GSK plc. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license